To further address KKS activation in patients with COVID-19, we performed HK Western blot, and we observed nearly threefold increase in relative level of HK proteolytically cleaved forms in plasma from patients with COVID-19 compared to healthy controls (Figures 1E, F), which could confirm contact pathway activation. Here, KNG1 is linked to COVID-19.